James Finn
Sep 13, 2021

--

The story is little different than with life-saving insulin, which back in the 1990s when my late partner was a diabetic, was so inexpensive we barely considered the trivial impact on our household budget.

And why shouldn’t insulin be inexpensive? It’s simple to mass produce from very inexpensive raw materials. Drug companies never charged a lot for it, until …

Well, I’m sure you’ve heard the horror stories as well as I have. Drug companies have jacked insulin prices up astronomically in the last decade. Diabetics struggle to pay ridiculously high prices that have no basis in the cost of production or distribution.

Today, people sometimes die because they can’t afford their insulin. The drug companies? They just keep on keeping on.

Because in the United States today, business ethos has nothing to do with dignity or humanity.

--

--

James Finn
James Finn

Written by James Finn

James Finn is an LGBTQ columnist, a former Air Force intelligence analyst, an alumnus of Act Up NY, and an agented but unpublished novelist.

No responses yet